AMBEV S.A. current report, Q4 FY2014

Business Context and Reporting Period

This Form 6-K filing by AMBEV S.A. reports on a Board of Directors meeting held on December 1, 2014. The document serves as an extract of the minutes detailing corporate governance resolutions, specifically regarding capital structure adjustments and executive management changes effective January 1, 2015.

Key Financial Metrics

The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity for the period ending December 31, 2014. The only financial data disclosed relates to a specific capital transaction:

  • Capital Increase Amount: R$ 18,968,607.98
  • New Shares Issued: 2,296,939 common shares
  • Issuance Price: R$ 8.258211 per share
  • Funding Source: Capitalization of the Share-Based Payment Reserve (no cash inflow)
  • Updated Total Capital: R$ 57,575,213,777.73
  • Updated Total Shares Outstanding: 15,711,394,535 common shares

Material Changes

The filing details two material corporate actions:

  1. Capital Structure Adjustment: The Board approved a capital increase resulting from the exercise of stock options. This transaction increased the total number of outstanding shares and the total authorized capital without preemptive rights.
  2. Executive Management Change: The Board approved the replacement of the People and Management Executive Officer. Mr. Sandro de Oliveira Bassili was replaced by Mr. Fabio Vieira Kapitanovas, effective January 1, 2015.

Guidance, Outlook, and Risks

The filing text does not contain financial guidance, market outlook, management commentary on operational performance, or a discussion of risks and contingencies. The document is strictly limited to the ratification of the stock option exercise and the appointment of a new executive officer.

Investor Verification Checklist

  • Verify the impact of the 2,296,939 new shares on earnings per share (EPS) dilution in the 2015 fiscal year.
  • Confirm the effective date of the new People and Management Executive Officer (January 1, 2015) and the expiration of his mandate (July 31, 2016).
  • Review the full Stock Option Plan rules to understand the vesting and exercise conditions that led to this capitalization.
  • Check subsequent filings for the 2014 full-year financial results, as this 6-K does not contain them.